Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Angela M. DeVeaugh-Geiss"'
Publikováno v:
Drug and Alcohol Dependence Reports, Vol 10, Iss , Pp 100220- (2024)
Background: In 2021, approximately 60 million individuals worldwide and 9 million individuals in the United States (US) reported opioid misuse. In the US, 2.5 million have OUD, of which only about a third receive any substance abuse treatment. OUD is
Externí odkaz:
https://doaj.org/article/a91b9745a14b43f1842d0fb7be0643d4
Publikováno v:
Journal of addiction medicine.
Buprenorphine (Suboxone) is an effective treatment for opioid use disorder (OUD). However, there have been widespread reports of diversion and misuse. This study examined motivations for nonprescribed buprenorphine use among rural residents.Eligible
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e121d7fd6c54cf99573f6e0458384e03
https://pubmed.ncbi.nlm.nih.gov/36044288
https://pubmed.ncbi.nlm.nih.gov/36044288
Publikováno v:
Journal of Substance Use and Addiction Treatment. 147:208980
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab0f88e951368d4bbcce15ce085ab920
https://doi.org/10.1016/j.josat.2023.208980
https://doi.org/10.1016/j.josat.2023.208980
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 28:428-437
Objectives This study aims to describe the utilization patterns of atypical antipsychotics (AA) among insured patients with bipolar I disorder in the USA. Methods We studied patients with bipolar I disorder who newly initiated an oral AA between 2002
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a87e6d9fd88067c0da5a66e5d9bdb197
https://doi.org/10.1002/hup.2326
https://doi.org/10.1002/hup.2326
Autor:
Mitchell L. Kotler, Angela M. DeVeaugh-Geiss, Lisa R. Ramsay, Lilan H. Chen, Michael J. Durcan
Publikováno v:
Clinical Therapeutics. 32:1140-1148
A comparison of the 21-mg NiQuitin patch with other marketed nicotine patches reported significant differences in pharmacokinetic profiles, even among patches of the identical labeled dose strength. The 25-mg Nicorette Invisi patch became available i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92c35808c11f8672fc7eda1246129e08
https://doi.org/10.1016/j.clinthera.2010.06.008
https://doi.org/10.1016/j.clinthera.2010.06.008
Autor:
Angela M DeVeaugh-Geiss, Bradley N. Gaynes, William C. Miller, Betsy Sleath, Suzanne L. West, Kurt Kroenke
Publikováno v:
Journal of Affective Disorders. 123:283-290
Background Comorbid panic symptoms may complicate depression treatment. However, most research focuses on specialty care, and the evidence in primary care is mixed. Methods We analyzed data from a randomized trial investigating Selective Serotonin Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d37f43ff9b406789355f75334386308
https://doi.org/10.1016/j.jad.2009.09.013
https://doi.org/10.1016/j.jad.2009.09.013
Autor:
Patricia Thieda, Erin E. Krebs, Gerald Gartlehner, Angela M DeVeaugh-Geiss, Bradley N. Gaynes, Kathleen N. Lohr, Richard A. Hansen
Publikováno v:
Drug Safety. 31:851-865
Background: Evidence indicates that only minor differences in efficacy exist among second-generation antidepressants for the treatment of major depressive disorder (MDD). However, a comprehensive assessment of both benefits and harms is crucial to ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b364e9fc3c92090cdd8f8bb62c703062
https://doi.org/10.2165/00002018-200831100-00004
https://doi.org/10.2165/00002018-200831100-00004
Publikováno v:
Human psychopharmacology. 28(5)
This study aims to describe the utilization patterns of atypical antipsychotics (AA) among insured patients with bipolar I disorder in the USA.We studied patients with bipolar I disorder who newly initiated an oral AA between 2002 and 2008. Utilizati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::96f55d4f29bc4bb0ee687df2994a6fe6
https://pubmed.ncbi.nlm.nih.gov/23861367
https://pubmed.ncbi.nlm.nih.gov/23861367
Autor:
Richard A. Hansen, Patricia Thieda, Laura C Morgan, Erin E. Krebs, Kathleen N. Lohr, Bradley N. Gaynes, Gerald Gartlehner, Angela M DeVeaugh-Geiss
Publikováno v:
Psychosomatics. 49(3)
Background Approximately two-thirds of patients with depression experience physical pain symptoms. Coexisting pain complicates the treatment of depression and is associated with worse depression outcomes. Objective The authors reviewed the effect of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef27136f201a4ad898bde63586329122
https://pubmed.ncbi.nlm.nih.gov/18448772
https://pubmed.ncbi.nlm.nih.gov/18448772